Fazadinium bromide
Chemical compound
- M03AC08 (WHO)
- (E)-bis(3-methyl-2-phenylimidazo[3,2-a]
pyridin-4-ium-1-yl)diazene dibromide
- 49564-56-9
N
- 6321422
- 21161354 N
- 8WV5538LFK
- D07273
Y
- DTXSID4023040
- Interactive image
- Cc1c(n(c2[n+]1cccc2)N=Nn3c4cccc[n+]4c(c3c5ccccc5)C)c6ccccc6.[Br-].[Br-]
InChI
- InChI=1S/C28H24N6.2BrH/c1-21-27(23-13-5-3-6-14-23)33(25-17-9-11-19-31(21)25)29-30-34-26-18-10-12-20-32(26)22(2)28(34)24-15-7-4-8-16-24;;/h3-20H,1-2H3;2*1H/q+2;;/p-2N
- Key:LBOZSXSPRGACHC-UHFFFAOYSA-LN
N
Y (what is this?) (verify)Fazadinium bromide is a muscle relaxant which acts as a nicotinic acetylcholine receptor antagonist through neuromuscular blockade.[1]
References
- ^ Camu F, D'Hollander A (1978). "Neuromuscular blockade of fazadinium bromide (AH 8165) in renal failure patients". Acta Anaesthesiologica Scandinavica. 22 (3): 221–6. doi:10.1111/aas.1978.22.3.221. PMID 27936.
- v
- t
- e
Skeletal muscle relaxants (M03)
(primarily antinicotinic,
NMJ block)
| Non-depolarizing |
| ||||
|---|---|---|---|---|---|
| Depolarizing |
| ||||
| ACh release inhibitors |
 | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
